Closys Rinse
NDC Package 58578-0613-7
Package Information
Closys (hydrogen peroxide) rinses is adults and children 12 years of age and olderUse 10 mL (two teaspoons) around in the mouth over affected areas for at least 1 minute and spit out Use up to 4 times daily after meals and at bedtime or as directed by a dentist or physician Children 6 years to under 12 years of age: supervise useChildren under 6 years of age: do not use. This formulation utilizes a rinse delivery system. Marketed by Rowpar Pharmaceuticals, Inc., this product is identified by NDC 58578-0613 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 358975 - hydrogen peroxide 1.5 % Mouthwash
- RxCUI: 358975 - hydrogen peroxide 15 MG/ML Mouthwash
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58578 - Rowpar Pharmaceuticals, Inc.
- 58578-0613 - Closys
- 58578-0613-7 - 3 BOTTLE in 1 PACKAGE / 473 mL in 1 BOTTLE
- 58578-0613 - Closys
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (58578-0613). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58578-0613-7 identifies a specific commercial package of 3 bottle in 1 package / 473 ml in 1 bottle of Closys, a human over the counter drug labeled by Rowpar Pharmaceuticals, Inc.. This rinse is formulated for oral use and contains hydrogen peroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rowpar Pharmaceuticals, Inc. on January 27, 2025. The current certification is valid through December 31, 2026.
How is this Rowpar Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58578061307. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.